title: Cost-Effectiveness of Aprepitant in Egyptian Patients Receiving Highly Emetogenic Therapy from the Third Party Payer Perspective.
authors.affiliation: CAPA, Cairo, Egypt.
authors.forename: M
authors.initials: M
authors.lastname: Helal
authors.affiliation: Central Administration for Pharmaceutical Affairs, Cairo, Egypt.
authors.forename: G
authors.initials: G
authors.lastname: Elsisi